Skip to content

Celcuity CELC Convertible Debt (Non-Current)

Convertible Debt (Non-Current) at other companies

Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$223.17M

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:ConvertibleDebtNoncurrent.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's convertible debt (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's convertible debt (non-current)?
Celcuity (CELC) reported convertible debt (non-current) of $195.57M in Q1 2026.
What does convertible debt (non-current) mean?
This represents the principal amount of debt obligations that can be converted into equity and are due for repayment beyond a one-year horizon. It serves as a measure of long-term leverage and potential future dilution for existing shareholders upon conversion.